IOSP Financials: Revenue Breakdown, Margins & Competitor Comparison
The article provides a financial analysis of Innospec Inc (IOSP), detailing its revenue breakdown, profitability margins, and a comparison with competitors. IOSP's primary revenue driver is Fuel Specialties, accounting for 38.9% of total sales, with strong gross and net margins. The analysis benchmarks IOSP's performance against industry leaders like HUN and NGVT, highlighting its competitive positioning within the Specialty Chemicals sector.
IOSP Stock News Today | Earnings, Events & Price Alerts
The article provides news and events related to IOSP stock, including recent earnings reports and upcoming financial events. Innospec Inc. reported Q4 2025 earnings, with revenues of $455.6 million, and discussed continued strong performance in Fuel Specialties and improving results in Performance Chemicals and Oilfield Services. The company expects further improvements in 2026 due to strategic initiatives.
Tudor Investment Corp ET AL Lowers Holdings in Innospec Inc. $IOSP
Tudor Investment Corp ET AL significantly reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 81.5% in the third quarter, leaving it with 4,215 shares valued at $325,000. Despite this, Innospec reported stronger-than-expected Q3 earnings per share of $1.50, though revenue fell slightly year-over-year. The company has a current market capitalization of $1.83 billion, with institutional investors and hedge funds owning 96.64% of the stock.
Allspring Global Investments Trims Stake in Innospec
Allspring Global Investments reduced its stake in Innospec Inc. by 1.5% in the fourth quarter of 2025, selling 35,246 shares. Despite this trim, the firm still holds a significant position of 2,356,503 shares valued at approximately $179.8 million, representing about 9.51% of Innospec's outstanding shares. This move suggests a potential view of limited short-term upside for the specialty chemicals company, while maintaining confidence in its long-term prospects.
Allspring Global Investments Holdings LLC Sells 35,246 Shares of Innospec Inc. $IOSP
Allspring Global Investments Holdings LLC reduced its stake in Innospec Inc. by 1.5% in the fourth quarter, selling 35,246 shares but still holding 2,356,503 shares valued at approximately $179.8 million. Other institutional investors adjusted their holdings, while company insiders sold 4,989 shares totaling $391,889 over the past three months. Innospec reported better-than-expected Q4 EPS but slightly missed revenue estimates, and analysts currently have a "Reduce" consensus rating on the stock.
(IOSP) Price Dynamics and Execution-Aware Positioning
This article from Stock Traders Daily discusses the price dynamics and execution-aware positioning for Innospec Inc. (NASDAQ: IOSP). It highlights a potential shift in positive near-term sentiment, broader weak alignment, and an exceptional risk-reward short setup. The analysis provides AI-generated strategies including Position Trading, Momentum Breakout, and Risk Hedging, along with multi-timeframe signal analysis for various horizons.
Innospec, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation following a challenging year with a -25.87% return. Despite this decline, the company boasts competitive financial metrics including a high dividend yield of 1051.30% and favorable P/E (14) and EV to EBITDA (8.49) ratios compared to industry peers like Eastman Chemical Co. and Element Solutions, Inc. The company's current price is $72.20, slightly down from its previous close.
Drag Reducing Agent Market Is Booming Rapidly with Strong Demand
Coherent Market Insights has published a new research study on the Global "Drag Reducing Agent Market" expected to grow from 2026 to 2033. The report segments the market by product type, application, end-user, and region, providing an in-depth analysis of market trends, competitive landscape, and key players like Innospec Inc., Baker Hughes Company, and The Lubrizol Corporation. It offers insights into market drivers, restraints, and opportunities, aimed at aiding strategic decision-making for businesses.
Revenue per share of Innospec Inc. – FWB:OCT
This article focuses on the revenue per share of Innospec Inc. (FWB:OCT), providing financial data and market information. It highlights the company's presence on the Frankfurt Stock Exchange and mentions that market data is provided by ICE Data Services and FactSet.
Short Interest in Innospec Inc. (NASDAQ:IOSP) Decreases By 24.3%
Innospec Inc. (NASDAQ:IOSP) saw a significant 24.3% decrease in short interest during March, falling to 321,014 shares, which represents about 1.3% of the stock. Insider selling also occurred, with two directors selling shares, and a total of 4,989 shares being disposed of by insiders over the last 90 days. Despite a revenue decline of 2.4%, the company beat EPS expectations, reporting $1.50 against an estimated $1.26.
Innospec Inc Stock: Specialty Chemicals Leader with Strong Profit Margins and Institutional Interest
Innospec Inc. is highlighted as a specialty chemicals leader with strong profit margins, particularly in fuel additives, personal care, and industrial sectors. The company's diversified portfolio allows it to maintain superior margins compared to the industry average. Recent institutional activities, such as Assenagon Asset Management S.A. increasing its stake, affirm investor confidence, and the article suggests that Innospec's stable operations and high-value product focus make it appealing to long-term holders despite sector-specific risks.
Vanguard disaggregates holdings; The Vanguard Group reports 0 shares for IOSP (IOSP)
The Vanguard Group has filed an amended Schedule 13G/A for Innospec Inc. (IOSP), reporting beneficial ownership of 0 shares (0%) of Common Stock. This filing reflects an internal realignment completed on January 12, 2026, where certain Vanguard subsidiaries now report their ownership separately, in accordance with SEC Release No. 34-39538. Ashley Grim, Head of Global Fund Administration, signed the amendment.
Assenagon Asset Management S.A. Acquires 48,807 Shares of Innospec Inc. $IOSP
Assenagon Asset Management S.A. increased its stake in Innospec Inc. by 37.7%, acquiring an additional 48,807 shares to now own 178,204 shares, representing approximately 0.72% of the company. The acquired shares are valued at $13.64 million, according to its latest 13F filing. Innospec reported a quarterly EPS of $1.50, beating estimates, despite a 2.4% year-over-year revenue decrease, and has an average "Reduce" rating from analysts.
[ARS] INNOSPEC INC. SEC Filing
This article announces an ARS SEC filing by Innospec Inc. (IOSP) on March 24, 2026, which is available as a PDF document. It also provides an overview of Innospec Inc.'s stock data, recent news, and other SEC filings. The filing has a low impact and neutral sentiment according to Rhea-AI.
Innospec (IOSP) down 21.8% since last earnings report: Can it rebound?
This article from MSN is missing its content. It references Innospec (IOSP) being down 21.8% since its last earnings report and poses the question of whether it can rebound, but does not provide details to answer that question.
Is Innospec (IOSP) Now At An Attractive Price After Recent Share Price Slide
Innospec (IOSP) has experienced a significant share price slide of nearly 30% over the last year. Despite this, a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 18.9%, trading below its estimated intrinsic value of $81.27 per share against a recent close of $65.89. Furthermore, its current P/E ratio of 14.0x is below both the industry average and Simply Wall St's proprietary "Fair Ratio" of 17.0x, indicating potential undervaluation based on fundamentals.
IOSP SEC Filings - Innospec Inc 10-K, 10-Q, 8-K Forms
This page provides access to U.S. Securities and Exchange Commission filings for Innospec Inc. (NASDAQ: IOSP), an international specialty chemicals company, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material events. The filings offer detailed information about the company’s operations across its Performance Chemicals, Fuel Specialties, and Oilfield Services segments, capital structure, and governance. Stock Titan updates these filings as they are released on EDGAR, offering AI-powered summaries to highlight key points for investors.
Innospec (IOSP) down 21.8% since last earnings report: Can it rebound?
This article from MSN discusses Innospec (IOSP) stock performance, noting a 21.8% decline since its last earnings report. It poses the question of whether the company can rebound. The content is concise, focusing on the immediate impact of recent financial news on the stock.
Innospec, Inc. Hits New 52-Week Low at USD 66.33
Innospec, Inc. has fallen to a new 52-week low of USD 66.33, reflecting a significant decline of 46.0% over the past year, underperforming the S&P 500. Despite a high dividend yield, the company faces challenges including a 26.29% net profit decline and low operating cash flow, leading to ongoing market pressures. This performance highlights the need to examine its financial health and operational strategies more closely.
Innospec, Inc. Hits 52-Week Low at $67.37 Amid Significant Decline
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals industry, has hit a new 52-week low of $67.37. The stock has seen a significant decline of 45.76% over the past year, contrasting with the S&P 500's 17.99% gain. Despite a high dividend yield and institutional holdings at 100%, the company faces challenges with declining net profit and operating cash flow.
(IOSP) as a Liquidity Pulse for Institutional Tactics
This article analyzes Innospec Inc. (NASDAQ: IOSP) revealing weak sentiment across all time horizons, supporting a short bias. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, alongside multi-timeframe signal analysis indicating support and resistance levels. The report highlights elevated downside risk due to a lack of long-term support signals.
Innospec stock hits 52-week low at $67.83 amid challenging year By Investing.com
Innospec Inc. (NASDAQ:IOSP) stock has fallen to a new 52-week low of $67.83, marking a 30.95% decline over the past year due to market volatility and sector challenges. Despite this downturn, InvestingPro analysis indicates the stock is undervalued with a "GOOD" financial health score and active share buybacks. The company has also been identified by Wolfe Research as highly attractive for activist investors.
Innospec stock hits 52-week low at $67.83 amid challenging year By Investing.com
Innospec Inc. (NASDAQ:IOSP) has seen its stock price drop to a new 52-week low of $67.83, reflecting a 30.95% decline over the past year due to market volatility and sector challenges. Despite this, InvestingPro analysis suggests the stock is undervalued, maintaining a "GOOD" financial health score and trading at a P/E ratio of 14.71. Management has been actively buying back shares, and the company is also being monitored by Wolfe Research for its potential vulnerability to activist investors.
IOSP SEC Filings - Innospec Inc 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to Innospec Inc. (IOSP) SEC filings, including annual 10-K reports, quarterly 10-Q statements, and 8-K material event disclosures, along with insider trading forms. It details the company's operations across its Performance Chemicals, Fuel Specialties, and Oilfield Services segments. The platform also offers AI-powered summaries to help investors quickly understand key points from these regulatory documents.
IOSP SEC Filings - Innospec Inc 10-K, 10-Q, 8-K Forms
This page provides access to Innospec Inc.'s (IOSP) U.S. Securities and Exchange Commission filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material events. It details recent insider transactions such as share sales, tax withholdings, and restricted stock unit grants for several executives. The platform also offers AI-powered summaries to help investors quickly understand the key points of various regulatory documents.
Innospec stock hits 52-week low at $67.83 amid challenging year
Innospec Inc. (NASDAQ:IOSP) has reached a new 52-week low of $67.83, marking a 30.95% drop over the past year due to market volatility and sector challenges. Despite this, InvestingPro analysis suggests the specialty chemicals company is undervalued with a "GOOD" financial health score and trades at a P/E ratio of 14.71. Management has been actively buying back shares, and the RSI indicates the stock is oversold, while Wolfe Research has also flagged Innospec as highly attractive to activist investors.
A Look At Innospec (IOSP) Valuation After Recent Share Price Weakness
Innospec (IOSP) has seen a significant share price decline, dropping 20.46% in the past month and 12.78% over three months. Despite this, the company appears undervalued with a fair value of $99.33 compared to its current trading price of $68.87, according to Simply Wall St's analysis and analyst consensus. Investors are encouraged to review the full narrative and consider potential risks and rewards.
A Look At Innospec (IOSP) Valuation After Recent Share Price Weakness
Innospec (IOSP) has experienced a significant share price decline, dropping 20.46% in the past month and 12.78% over three months. Despite this, the company is seen as undervalued, with a narrative fair value of $99.33 against its current price of $68.87, and analysts anticipate strong future earnings growth. Investors are encouraged to review the underlying assumptions and consider other investment opportunities based on their risk tolerance and financial goals.
Innospec, Inc. Hits New 52-Week Low at $67.85 Amidst Market Struggles
Innospec, Inc. has reached a new 52-week low of $67.85, marking a significant 44.88% decline in its stock performance over the past year. The company, a small-cap player in the Chemicals & Petrochemicals industry with a market capitalization of USD 2,411 million, faces challenges including a negative net profit growth rate and low operating cash flow. Despite a high dividend yield, Innospec has consistently underperformed against market benchmarks.
Innospec Inc Stock (ISIN: US45768S1033) Eyes Steady Growth Amid Specialty Chemicals Resilience
Innospec Inc. (IOSP) demonstrates resilience in the specialty chemicals sector, with its stock trading around $74.52 and exhibiting positive analyst sentiment. The company benefits from a diversified portfolio, strong cash flow, and low leverage, which position it for growth despite market volatility and input cost pressures. While some peers show higher gains, Innospec's steady performance and strategic focus on high-margin specialties offer stability for investors.
Innospec, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
Innospec, Inc., a small-cap chemicals company, is facing a challenging market, reflected in its stock performance and bearish technical indicators. The company's stock has significantly underperformed the S&P 500 over the past year and month, with a current price of $68.83. Technical analysis, including MACD and Bollinger Bands, points to a bearish sentiment, although the KST offers mixed signals.
Medina Value Partners LLC Makes New Investment in Innospec Inc. $IOSP
Medina Value Partners LLC has made a new investment in Innospec Inc. (NASDAQ:IOSP), acquiring 235,956 shares valued at approximately $18.21 million, making it their 12th largest holding. Despite beating EPS expectations, Innospec missed on revenue, and experiences high institutional ownership alongside mixed analyst views and insider selling.
Innospec Inc Stock (ISIN: US45768S1033) Holds Steady Amid Specialty Chemicals Sector Resilience
Innospec Inc. (ISIN: US45768S1033) demonstrates stability in the specialty chemicals sector, appealing to investors with its diversified portfolio across fuel specialties, performance chemicals, and oilfield chemicals. The company benefits from high-margin, innovation-driven products and a strong market position in sustainable sectors, especially in fuel additives and oilfield applications. Its financial model, characterized by robust gross margins and strong free cash flow, supports dividends and strategic M&A, making it an attractive option for investors seeking defensive growth.
First Trust Advisors LP Trims Stock Holdings in Innospec Inc. $IOSP
First Trust Advisors LP reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 20.2% in the third quarter, selling 161,942 shares and ending with 640,562 shares valued at approximately $49.4 million. Insiders also sold nearly 5,000 shares, decreasing their ownership to 1.31%. Despite beating EPS estimates, Innospec's revenue missed expectations and analysts currently rate the stock as "Reduce."
Innospec Inc. (NASDAQ:IOSP) Q4 2025 earnings call transcript
This document contains the Q4 2025 earnings call transcript for Innospec Inc. (NASDAQ:IOSP). It would typically detail financial results, company performance, and management's outlook for the upcoming periods.
What's Driving Innospec Stock in FY26 After the Winter Storm
Innospec Inc. (IOSP) is facing a soft first half in 2026 due to disruptions from a late-January winter storm, particularly impacting its Performance Chemicals and Oilfield Services segments. While the Fuel Specialties segment provides stability, investors are advised to monitor the execution of recovery plans in the other segments to gauge the stock's potential for a second-half rebuild. The article emphasizes that lost volumes in Performance Chemicals are not expected to be recovered, pushing the company's financial recovery later into the year.
Director at Innospec (IOSP) amends filing after 594-share stock sale
Innospec Inc. Director David Landless filed an amended Form 4 to correct previously reported transaction prices for the sale of 594 shares of common stock. The sales occurred in two open-market transactions on February 27, 2026, at weighted average prices of $76.30 and $76.79. Following these transactions, Landless directly holds 7,632 shares of Innospec common stock.
What's Driving Innospec Stock in FY26 After the Winter Storm
Innospec (IOSP) is facing a reset in the first half of 2026 due to disruptions from a severe winter storm, impacting its Performance Chemicals and Oilfield Services segments. While Fuel Specialties provides a steady base, the company's full-year recovery depends on execution in Performance Chemicals and regional performance in Oilfield Services. Investors will need to monitor second-half improvements in margins, efficiency, and product ramps to rebuild confidence.
Storm Fallout and Segment Reset: What's Next for Innospec Stock?
Innospec (IOSP) is facing a soft first half of 2026 due to a severe winter storm, which caused operational disruptions and unrecoverable sales, particularly in its Performance Chemicals segment. While its Fuel Specialties segment is expected to remain stable, the company's uneven recovery path relies heavily on a second-half rebound in Performance Chemicals and Oilfield Services, with the latter's growth concentrated in the Middle East. Challenges like a Zacks Rank #4 (Sell) rating and risks in margin rebuild and execution timing mean investors should monitor tangible proof points for improvement.
Innospec stock hits 52-week low at $69.88
Innospec Inc (IOSP) stock has fallen to a 52-week low of $69.88, marking a 27% decline over the past year. Despite the downturn and oversold technical indicators, InvestingPro analysis suggests the stock is undervalued, boasting a "GOOD" financial health score, a strong balance sheet, and ongoing share buybacks.
DRAs and Changing Middle Eastern Market Dynamics Influence IOSP's Strategic Plan for FY26
Innospec Inc. (IOSP) anticipates a challenging first half of 2026 due to a winter storm, with growth drivers expected later in the year. The strategic plan focuses on expanding drag-reducing agents (DRAs) in Oilfield Services, particularly in the Middle East, and improving margins in Performance Chemicals through efficiency and new products. Fuel Specialties is expected to remain a stable contributor, providing a foundation for the company's planned recovery and growth.
(IOSP) Risk Channels and Responsive Allocation
Innospec Inc. (NASDAQ: IOSP) is showing weak sentiment across all horizons, supporting a short bias. The AI models indicate a mid-channel oscillation pattern with an exceptional 31.1:1 risk-reward setup, targeting a 9.0% gain versus a 0.3% risk. Different trading strategies (Position, Momentum Breakout, Risk Hedging) are outlined, along with multi-timeframe signal analysis indicating weak signals across near-term, mid-term, and long-term horizons.
Director at Innospec (IOSP) amends Form 4 after selling 119 common shares
Innospec Inc. director Claudia Poccia amended a Form 4 filing to correct the transaction prices for two open-market sales of 119 common shares on February 27, 2026. The amended filing clarifies that 57 shares were sold at a weighted average price of $76.30 and 62 shares at $76.79, and specifies the price ranges for these multi-transaction sales. Following these transactions, Poccia directly owned 6,508 shares of Innospec common stock.
Innospec (IOSP) director amends Form 4 after selling 594 common shares
Innospec Inc. director Larry Padfield filed an amended Form 4 (Form 4/A) to correct previously reported transaction prices for the sale of 594 common shares. On February 27, 2026, he sold 287 shares at a weighted average price of $76.30 and 307 shares at $76.79. After these transactions, his direct ownership totaled 9,453 shares of Innospec common stock.
Quantbot Technologies LP Sells 14,081 Shares of Innospec Inc. $IOSP
Quantbot Technologies LP significantly reduced its stake in Innospec Inc. (NASDAQ:IOSP) by 45.3% in the third quarter, selling 14,081 shares and retaining 16,971 shares valued at approximately $1.31 million. Analyst ratings for Innospec are mixed, with one firm upgrading to "buy" while others downgraded to "strong sell" and "hold," resulting in a consensus "Reduce" rating from MarketBeat. Insiders have been net sellers, and the company recently surpassed EPS estimates but slightly missed on revenue.
Innospec, Inc. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators
Innospec, Inc., a small-cap chemicals company, has seen a revision in its stock evaluation due to mixed technical indicators and a recent price decline. While some indicators show bullish trends on a weekly basis, others suggest bearish movements, and the stock's performance has significantly lagged behind the S&P 500 over the past year. The company's current price is $74.22, down from a previous close of $77.02, highlighting challenges in the current market environment.
[Form 4/A] INNOSPEC INC. Amended Insider Trading Activity
INNOSPEC INC. director Milton C. Blackmore filed an amended Form 4 (4/A) to correct previously reported details of stock sales made on February 27, 2026. The amendment clarifies that 594 shares were sold in two separate open-market transactions at weighted average prices of $76.30 and $76.79 per share, correcting initial filings which did not specify these were weighted averages across multiple trades within broader price ranges. Following these transactions, Blackmore's direct holdings in INNOSPEC common stock were reduced to 10,530 shares.
Innospec Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently formed a Golden Cross, a technical indicator suggesting a potential bullish shift in momentum. This occurs despite a 25.93% decline over the past year, and could signal a recovery for the company, which has a market capitalization of $1.94 billion and a P/E ratio of 16.67. Investors will be monitoring this development to see how it influences Innospec's future trajectory.
Assessing Innospec (IOSP) Valuation After Recent Share Price Weakness
Innospec (IOSP) has experienced recent share price weakness, with a 6.5% decline over the past month, despite a slightly positive 90-day return. The stock is currently trading at US$76.37, modestly below its estimated fair value of $99.33, presenting a potential undervaluation. Analysts point to updated assumptions for discount rate, revenue growth, profit margin, and future P/E as drivers for this view, though risks like raw material costs and potential revenue weakness in Oilfield Services exist.
Innospec (NASDAQ: IOSP) SVP disposes shares for tax withholding
Corbin Barnes, SVP of Corporate Development and Investor Relations at Innospec Inc. (NASDAQ: IOSP), reported a disposition of 166 common shares. These shares, valued at $78.34 each, were withheld by the company to cover income tax liabilities incurred upon the vesting of a restricted stock unit award on February 27, 2026. This transaction was not an open-market sale, and Barnes now directly holds 13,079.6117 shares.
